This special event will feature distinguished members of the Company’s Scientific Advisory Board, who will share insights into Psyence BioMed’s ongoing clinical development programs as well as provide a forward-looking perspective on future strategic initiatives. The session is designed to give participants a deeper understanding of the Company’s progress, vision, and the significant opportunities that lie ahead.

We are honored to welcome an esteemed panel of experts, including Dan Stein, Seth Feuerstein, Albert Garcia-Romeu, and Clive Ward-Able, each of whom brings invaluable expertise and perspective to the discussion. Their contributions will help illuminate Psyence BioMed’s commitment to advancing innovative therapies and delivering meaningful impact in the field.

To ensure your place at this important event, please register in advance using the link provided below. We look forward to your participation in what promises to be an insightful and engaging session.